Serial #99224920
LIVE

Serial Number

99224920

Owner

Anivance AI Corporation

Attorney

Michael T. Smith

Filing Date

Jun 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99224920 Trademark

Serial Number: 99224920

Serial #99224920 is a trademark filed by Anivance AI Corporation on June 9, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Anivance AI Corporation (2 trademarks)

1F., No. 118, Siwei Street,
Zhubei City, Hsinchu County R.O.C. , TW

Entity Type: 99

Trademark Details

Filing Date

June 9, 2025

Registration Date

Not Registered

Published for Opposition

January 6, 2026

Goods & Services

Organ-on-a-chip for laboratory and research purposes; Biotechnology instruments in the nature of microscopes; Microfluidic systems comprised of electric microfluidic sensors and microfluidic chips; Cell culture devices for laboratory use, namely, cell culture dishes, and tissue culture flasks; Scientific laboratory research instruments for DNA analysis; Biological simulation devices in the nature of medical training simulators; Diagnostic microfluidic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, DNA analysis, and thermal imaging; In vitro diagnostic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, and DNA analysis

Research and development services in the field of biotechnology; Organ-on-a-chip development and design; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals; Technical consultation and support services in the field of biosequestration of carbon dioxide; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals in the field of cellular biology; Laboratory services for the production of pharmaceuticals in the nature of providing simulations of cells in the field of cellular biology; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of human tissue for cellular biology purposes; Research and development in the field of cellular biology; Development of biological simulation systems; Development of microfluidic technology; Diagnostic services for organ-on-a-chip systems; Medical research services in the field of regenerative medicine

Medical diagnostic services; Personalized medical services in the nature of emergency medical services; Health assessment services and managed health care services; Medical evaluation of cell therapy

Artificial organ-on-a-chip for medical use; Diagnostic microfluidic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; In vitro diagnostic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Cell therapy devices in the nature of medical devices being tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical testing chips being lab-on-a-chip in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Medical biological simulation devices in the nature of medical diagnostic apparatus for detecting disease progression and also incorporating recorded software for simulating organ functions and drug interactions; Medical instruments, namely, biosensors for detecting infectious diseases; Cell culture devices in the nature of cell culture apparatus for medical use, namely, cell culture chambers

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 31, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 29, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 17, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 9, 2025 MAFR
NEW APPLICATION ENTERED
Jun 9, 2025 NWAP